3-deazaneplanocin
2物価
選択條件:
ブランド
- 関東化學(xué)株式會(huì)社(KANTO)
パッケージ
- 1mg
- 5mg
- 生産者関東化學(xué)株式會(huì)社(KANTO)
- 製品番號(hào)49077-15
- 製品説明
- 英語(yǔ)製品説明3-Deazaneplanocin A
- 包裝単位5mg
- 価格¥92000
- 更新しました2021-03-23
- 購(gòu)入
- 生産者関東化學(xué)株式會(huì)社(KANTO)
- 製品番號(hào)49077-16
- 製品説明
- 英語(yǔ)製品説明3-Deazaneplanocin A
- 包裝単位1mg
- 価格¥34000
- 更新しました2021-03-23
- 購(gòu)入
生産者 | 製品番號(hào) | 製品説明 | 包裝単位 | 価格 | 更新時(shí)間 | 購(gòu)入 |
---|---|---|---|---|---|---|
関東化學(xué)株式會(huì)社(KANTO) | 49077-15 | 3-Deazaneplanocin A |
5mg | ¥92000 | 2021-03-23 | 購(gòu)入 |
関東化學(xué)株式會(huì)社(KANTO) | 49077-16 | 3-Deazaneplanocin A |
1mg | ¥34000 | 2021-03-23 | 購(gòu)入 |
プロパティ
沸點(diǎn) :624.1±65.0 °C(Predicted)
比重(密度) :1.75
貯蔵溫度 := -70C
溶解性 :Soluble in DMSO (up to 20 mg/ml)
外見(jiàn) :Liquid
酸解離定數(shù)(Pka) :13.52±0.70(Predicted)
色 :Beige
水溶解度 :Soluble in Water
安定性: :Stable for 1 year from date of purchase as supplied. Solutions in DMSO may be stored at -20°C for up to 1 month.
比重(密度) :1.75
貯蔵溫度 := -70C
溶解性 :Soluble in DMSO (up to 20 mg/ml)
外見(jiàn) :Liquid
酸解離定數(shù)(Pka) :13.52±0.70(Predicted)
色 :Beige
水溶解度 :Soluble in Water
安定性: :Stable for 1 year from date of purchase as supplied. Solutions in DMSO may be stored at -20°C for up to 1 month.
安全情報(bào)
絵表示(GHS): | ||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
注意喚起語(yǔ): | Warning | |||||||||||||||||||||||||||||||||||
危険有害性情報(bào): |
|
|||||||||||||||||||||||||||||||||||
注意書(shū)き: |
|
説明
The lysine methyltransferase EZH2 (KMT6), part of the polycomb repressive complex 2, catalyzes trimethylation of lysine 27 on histone H3 and is involved in proliferation and aggressive cell growth associated with neoplastic cells. 3-Deazaneplanocin A is a cyclopentenyl analog of 3-deazaadenosine, originally synthesized as an inhibitor of S-adenosyl-L-homocysteine hydrolase. It has been shown to deplete EZH2 levels and to inhibit trimethylation of lysine 27 on histone H3 in cultured human acute myeloid leukemia (AML) HL-60 and OCI-AML3 cells and in primary AML cells in a dose-dependent manner (0.2-1 μM). 3-Deazaneplanocin A treatment of cultured human AML cells induces increased expression of the cell-cycle regulators p21, p27, and FBXO32, leading to cell cycle arrest and apoptosis. When used in combination with the pan-histone deacetylase inhibitor panobinostat (10 mg/kg), 3-deazaneplanocin A’s (1 mg/kg) antileukemic effects are synergistically enhanced in mice implanted with AML cells.関連商品価格
- N,N-ジエチルベンズアミド
¥5500-201600 - ロスコビチン
¥7700-91700 - 2-(4-ピリジニルメチルアミノ)-N-[3-(トリフルオロメチル)フェニル]ベンズアミド
¥20600-495800